Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer
Kevin Lin(The University of Texas MD Anderson Cancer Center), Kris C. Wood(Duke University), Lucie Ahn(Case Western Reserve University), Antoine Forget(Centre National de la Recherche Scientifique), Reinaldo Dal Bello(Centre National de la Recherche Scientifique), Bryann Pardieu(Centre National de la Recherche Scientifique), Katherine R. Singleton(Duke University), Lorin Crawford(Microsoft (United States)), Abigail Xie(Duke University), Alexandre Puissant(Délégation Paris 5), Raiyan T. Sobhan(Duke University), Jason W. Locasale(Duke University), Peter Winter(Duke University), Grace R. Anderson(Duke University), Justine C. Rutter(Duke University), Emily T. Winn(Brown University), Ziwei Dai(Ministry of Education of the People's Republic of China), Amy E. Decker(Duke University), Raphaël Itzykson(Université Paris-Sud)
Cited by 91
Related Papers
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement
|Nature Biotechnology|2013|1.3k
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
|Nature Genetics|2011|1.1k